Amrutanjan Health Care Share Price
13 Nov, 2026 3:54 PM (IST)
Amrutanjan Health Care Performance
- Today's Low
- ₹507
- Today's High
- ₹519
- 52 Week Low
- ₹477
- 52 Week High
- ₹730
- Open Price₹507
- Previous Close₹509
- Volume32,092
- 50 DMA₹507.90
- 100 DMA₹517.80
- 200 DMA₹546.80
Amrutanjan Health Care Chart
Investment Returns
- Over 1 Month -0.12%
- Over 3 Month + 3.43%
- Over 6 Month -13.09%
- Over 1 Year -28.58%
Smart Investing Starts Here Start SIP with Amrutanjan Health Care for Steady Growth!
Amrutanjan Health Care Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 25.7
- PEG Ratio
- 24.5
- Market Cap Cr
- 1,470
- P/B Ratio
- 3.9
- Average True Range
- 15.1
- EPS
- 19.8
- Dividend Yield
- 1.2
- MACD Signal
- 2.8
- RSI
- 51.27
- MFI
- 78.65
Latest Stock News Updates
Investor Presentation for the Quarter Ended 30th September 2026
- BSE India
- 1 week 3 days ago
<h3><span style="font-size:16px;"><strong>Pharmaceuticals company Amrutanjan Health Care announced Q2FY27 results</strong></span></h3> <p><strong>Financial Highlights:</strong><!--TgQPHd|||[[2,[null,null,1,null,null,null,null,null,null,null,null,null,[351768,null,0]],[],null,1]]--></p> <ul data-complete="true" data-hveid="CAAICxAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="iwM4of_1k"> <li data-complete="true" data-hveid="CAAICxAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="iwM4of_1l"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="iwM4of_1n">Revenue from operations:<!--TgQPHd|||[]--></strong> For Q2FY27, revenue stood at Rs 13,517.89 lakh, showcasing a sequential jump of 31.28% QoQ against Rs 10,296.88 lakh in Q1FY27 and growing YoY by 14.85% over Rs 11,770.02 lakh in Q2FY26. For H1FY27, revenue reached Rs 23,814.77 lakh, an increase of 12.47% YoY from Rs 21,174.59 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICxAE" data-processed="true" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="iwM4of_1t"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="iwM4of_1v">Total income:<!--TgQPHd|||[]--></strong> For Q2FY27, total income achieved Rs 13,819.77 lakh, moving up 29.42% QoQ from Rs 10,678.36 lakh in Q1FY27 and increasing YoY by 13.36% compared to Rs 12,199.65 lakh in Q2FY26. For H1FY27, standalone total income rose to Rs 24,498.13 lakh, up 11.12% YoY over Rs 22,046.96 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICxAH" data-processed="true" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="iwM4of_21"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="iwM4of_23">Profit before tax (PBT):<!--TgQPHd|||[]--></strong> For Q2FY27, PBT arrived at Rs 2,309.59 lakh, pointing to an increase of 280.53% QoQ from Rs 606.94 lakh in Q1FY27 and climbing 20.20% YoY against Rs 1,921.49 lakh in Q2FY26. For H1FY27, standalone PBT registered at Rs 2,916.53 lakh, which represents a decline of 4.40% YoY against Rs 3,050.76 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICxAK" data-processed="true" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="iwM4of_29"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="iwM4of_2b">Profit after tax (PAT):<!--TgQPHd|||[]--></strong> For Q2FY27, PAT came in at Rs 1,727.99 lakh, scaling up sequentially by 295.81% QoQ over Rs 436.57 lakh in Q1FY27 and expanding 23.77% YoY over Rs 1,396.16 lakh in Q2FY26. For H1FY27, PAT arrived at Rs 2,164.56 lakh, marking a minor shift of -2.82% YoY relative to Rs 2,227.28 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAICxAN" data-processed="true" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="iwM4of_2h"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="iwM4of_2j">Earnings per equity share (EPS):<!--TgQPHd|||[]--></strong> Basic and diluted EPS for Q2FY27 stood at Rs 5.98, climbing sequentially by 296.03% QoQ from Rs 1.51 in Q1FY27 and increasing YoY by 23.81% compared to Rs 4.83 in Q2FY26. For H1FY27, basic EPS was Rs 7.49, down 2.73% YoY from Rs 7.70 in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--><br /> <!--TgQPHd|||[[2,[null,null,1,null,null,null,null,null,null,null,null,null,[351768,null,0]],[],null,1]]--></li> <!--TgQPHd|||[]--> </ul> <p><!--TgQPHd|||[]--></p> <p><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="iwM4of_32">Segment-wise Performance:</strong><!--TgQPHd|||[]--></p> <ul data-complete="true" data-hveid="CAAIDRAC" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="iwM4of_33"> <li data-complete="true" data-hveid="CAAIDRAD" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="iwM4of_34"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="iwM4of_36">OTC Products:<!--TgQPHd|||[]--></strong> Earned revenue of Rs 9,093.76 lakh in Q2FY27, tracking a sequential rise of 58.82% QoQ from Rs 5,725.83 lakh in Q1FY27 and up 13.65% YoY from Rs 8,001.84 lakh in Q2FY26. H1FY27 revenue reached Rs 14,819.59 lakh. Segment results for Q2FY27 were Rs 2,328.91 lakh compared to Rs 987.44 lakh in Q1FY27 and Rs 1,841.04 lakh in Q2FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDRAE" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="iwM4of_37"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="iwM4of_39">Women's Hygiene & Personal Care:<!--TgQPHd|||[]--></strong> Secured revenue of Rs 4,048.22 lakh in Q2FY27, up 11.34% QoQ from Rs 3,635.77 lakh in Q1FY27 and expanding YoY by 23.50% against Rs 3,278.04 lakh in Q2FY26. H1FY27 revenue reached Rs 7,683.99 lakh. Segment results for Q2FY27 stood at a positive Rs 46.19 lakh, turning around from a loss of Rs 287.61 lakh in Q1FY27 and a loss of Rs 125.74 lakh in Q2FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDRAF" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="iwM4of_3a"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="iwM4of_3c">Beverages:<!--TgQPHd|||[]--></strong> Recorded revenue of Rs 302.67 lakh in Q2FY27, down 64.95% QoQ from Rs 863.59 lakh in Q1FY27 and decreasing YoY by 29.42% relative to Rs 428.84 lakh in Q2FY26. H1FY27 segment revenue was Rs 1,166.26 lakh. Segment results tracked a loss of Rs 241.24 lakh in Q2FY27 compared to a loss of Rs 125.98 lakh in Q1FY27 and a loss of Rs 64.87 lakh in Q2FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDRAG" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="iwM4of_3d"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="iwM4of_3f">Others (Pain Management Centre):<!--TgQPHd|||[]--></strong> Brought in Rs 73.24 lakh in Q2FY27 against Rs 71.69 lakh in Q1FY27 and Rs 61.30 lakh in Q2FY26. H1FY27 revenue totaled Rs 144.93 lakh. Segment results were Rs 14.17 lakh in Q2FY27, relative to Rs 3.39 lakh in Q1FY27 and a loss of Rs 15.10 lakh in Q2FY26.</li> </ul> <p><a class="lb" href="/get-document/post/pdf/5927117/" target="_blank">Result PDF</a></p>
- Trendlyne
- 1 week 3 days ago
Outcome for the Unaudited Financial Results for the Quarter and Half Year Ended September 30, 2026
- BSE India
- 1 week 3 days ago
Amrutanjan Health Care Financials
Amrutanjan Health Care Technicals
EMA & SMA
- Bearish Moving Average 10
- Bullish Moving Average 6
- 20 Day
- ₹507.70
- 50 Day
- ₹507.90
- 100 Day
- ₹517.80
- 200 Day
- ₹546.80
Resistance and Support
- R3 528.20
- R2 523.60
- R1 516.00
- S1 503.80
- S2 499.20
- S3 491.60
Amrutanjan Health Care Corporate Actions - Bonus, Splits, Dividends
About Amrutanjan Health Care
Amrutanjan Health Care is engaged in the business of manufacture, supply, sale of products in pain management, congestion management, beverages and Women's Hygiene & Personal Care and services in pain management. View More- NSE Symbol
- AMRUTANJAN
- BSE Symbol
- 590006
- ISIN
- INE098F01031
Similar Stocks to Amrutanjan Health Care
Popular Stocks
Amrutanjan Health Care FAQs
Amrutanjan Health Care share price is ₹508 As on 14 November, 2026 | 15:03
The Market Cap of Amrutanjan Health Care is ₹1470 Cr As on 14 November, 2026 | 15:03
The P/E ratio of Amrutanjan Health Care is 25.7 As on 14 November, 2026 | 15:03
The PB ratio of Amrutanjan Health Care is 3.9 As on 14 November, 2026 | 15:03
The 52 week High & Low of Amrutanjan Health Care is ₹730/₹476.5 respectively As on 14 November, 2026 | 15:03
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.